BLENDS / DIRECT CATALOG PRICING
Tri-Heal Blend
Tri-Heal Blend is a vendor mixture described as TB-500, BPC-157, and KPV totaling 45 mg. Component ratios and the exact TB-500 sequence are not stated.
- Format
- Lyophilized research vial
- Listed formats
- 1
- Available now
- 0
- Catalog class
- Blends
Choose a listed format
- 45 mgRequest current pricingRequest pricing
Pricing, availability, quantity tiers, and member eligibility are checked again when an order is submitted.
TECHNICAL OVERVIEW
Identity first, claims kept in scope.
Tri-Heal Blend is a vendor mixture described as TB-500, BPC-157, and KPV totaling 45 mg. Component ratios and the exact TB-500 sequence are not stated.
The blends classification supports catalog navigation; it does not establish efficacy, safety, approval, human use, or equivalence to a material used in a cited study.
SPECIFICATIONS
- Material class
- Blends
- Physical format
- Lyophilized vial
- Research status
- Research purposes only
- Commerce status
- Contact for current availability
PLAIN-LANGUAGE RESEARCH SNAPSHOT
What researchers have actually studied.
Tri-Heal Blend is a vendor mixture described as TB-500, BPC-157, and KPV totaling 45 mg. Component ratios and the exact TB-500 sequence are not stated.
- Research covered
- KPV has cell and mouse-model evidence involving inflammatory signaling, and BPC-157 literature remains predominantly preclinical. No authoritative study of the exact three-component 45 mg Tri-Heal formulation was identified.
- Important limit
- Ingredient-level findings do not establish mixture interactions, stability, exposure, or outcomes. The incomplete formulation specification prevents independent verification.
FACTUAL FAQ
Tri-Heal Blend catalog questions
What formats are currently listed?
45 mg. Current price and stock state appear above.
What did researchers study?
KPV has cell and mouse-model evidence involving inflammatory signaling, and BPC-157 literature remains predominantly preclinical. No authoritative study of the exact three-component 45 mg Tri-Heal formulation was identified.
What is the most important evidence limit?
Ingredient-level findings do not establish mixture interactions, stability, exposure, or outcomes. The incomplete formulation specification prevents independent verification.
How should this listing be interpreted?
It is a research-material catalog listing, not medical guidance, a dosage recommendation, a safety or efficacy claim, or evidence of regulatory approval.
Where can I review related scientific references?
Use the PSC research library to locate general and compound-related source material. Open related research references →